scholarly journals Five-year single-center experience with the use of a subcutaneous implantable cardioverter-defibrillator for prevention of sudden cardiac death

2020 ◽  
Author(s):  
Maciej Kempa ◽  
Szymon Budrejko ◽  
Agnieszka Zienciuk-Krajka ◽  
Ludmiła Daniłowicz-Szymanowicz ◽  
Tomasz Królak ◽  
...  
Keyword(s):  
Sudden Cardiac Death ◽  
Implantable Cardioverter Defibrillator ◽  
Cardiac Death ◽  
Single Center ◽  
Cardioverter Defibrillator ◽  
Single Center Experience

scholarly journals Implantable cardioverter defibrillator to prevent sudden cardiac death in a patient with systemic sclerosis: A clinical case

2012 ◽  
Vol 5 (3) ◽  
pp. e166-e170 ◽  
Author(s):  
Fabio Marsico ◽  
Gianluigi Savarese ◽  
Celestino Sardu ◽  
Cristoforo D’Ascia ◽  
Donatella Ruggiero ◽  
...  
Keyword(s):  
Systemic Sclerosis ◽  
Sudden Cardiac Death ◽  
Implantable Cardioverter Defibrillator ◽  
Cardiac Death ◽  
Clinical Case ◽  
Cardioverter Defibrillator

scholarly journals LEFT VENTRICULAR LEAD IMPLANTATION FOR DETECTION OF VENTRICULAR ARRHYTHMIAS IN PATIENT WITH IMPLANTABLE CARDIOVERTER DEFIBRILLATOR AND LOW R WAVE IN RIGHT VENTRICLE

2021 ◽  
pp. 17
Author(s):  
Keyword(s):  
Sudden Cardiac Death ◽  
Right Ventricle ◽  
Implantable Cardioverter Defibrillator ◽  
Cardiac Death ◽  
Ventricular Arrhythmias ◽  
Systolic Function ◽  
Left Ventricular ◽  
Icd Implantation ◽  
Cardioverter Defibrillator ◽  
Ventricular Lead

Dilated cardiomyopathy (DCM) is a disease characterised as left ventricular (LV) or biventricular dilatation with impaired systolic function. Regardless of underlying cause patients with DCM have a propensity to ventricular arrhythmias and sudden cardiac death. Implantable Cardioverter Defibrillator (ICD) implantation for these patients results in significant reduction of sudden cardiac death [1-3]. ICD devices may be limited by right ventricle (RV) sensing dysfunction with low RV sensing amplitude. We present a clinical case of patient with DCM, implanted ICD and low R wave sensing on RV lead.

Tachycardias

2014 ◽  
pp. 243-260 ◽  
Keyword(s):  
Atrial Fibrillation ◽  
Sudden Cardiac Death ◽  
General Population ◽  
Implantable Cardioverter Defibrillator ◽  
Cardiac Death ◽  
Cardioverter Defibrillator ◽  
Priority Areas ◽  
Diagnosis And Management ◽  
Broad Complex

This chapter looks at the diagnosis and management of tachycardias, including both narrow complex tachycardias and broad complex tachycardias. Atrial fibrillation (AF) is the most common sustained arrhythmia, affecting 1–2% of the general population (5–15% of those over 80 years). There have been a number of developments in arrhythmia care over the last few years in particular in relation to AF and there are now more specialist arrhythmia nurses and nurse-led arrhythmia services than before. AF, arrhythmias, and sudden cardiac death are priority areas of NHS improvement. Recent guidelines for the management of tachycardias are discussed including pharmacological measure, cardioversion, and implantable cardioverter-defibrillator (ICD) insertion.

Sign in / Sign up

Export Citation Format

Share Document